GPC vs LAB · P/E 21, rev $23.49B vs rev $174.4M
Genuine Parts Co (GPC) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported GPC revenue for 2024-12-31 was $23.49B. Net income was $904.1M. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
GPC currently screens at market cap $17.60B and trailing P/E 20.7. LAB currently screens at market cap $317.1M.
Not investment advice. Open the GPC and LAB stock pages for the full models.
Not investment advice.